VANI Vivani Medical, Inc.

Fundamentals / CIK 0001266806 / USD

Vivani Medical, Inc. reported $0 in revenue and a net loss of $27.03M for the fiscal year ended December 31, 2025.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VANI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$11.56M$5.78M$0-$33.49MFY 2016 Revenue: $4.00MFY 2016 Net Income: -$33.18M2016FY 2017 Revenue: $7.96MFY 2017 Net Income: -$28.52M2017FY 2018 Revenue: $6.90MFY 2018 Net Income: -$35.09M2018FY 2019 Revenue: $3.38MFY 2019 Net Income: -$33.59M2019FY 2020 Net Income: -$14.88M2020FY 2021 Net Income: -$12.77M2021FY 2022 Net Income: -$13.89M2022FY 2023 Net Income: -$25.65M2023FY 2024 Revenue: $0FY 2024 Net Income: -$23.49M2024FY 2025 Revenue: $0FY 2025 Net Income: -$26.61M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 -- -- -- -- $3.38M $6.90M $7.96M $4.00M
Cost of Revenue -- -- -- -- $130K $500K $2.15M $4.89M $5.12M $10.08M
Gross Profit -- -- -- -- $130K $500K $1.23M $2.01M $2.85M -$6.09M
Research & Development $18.13M $15.74M $16.97M $14.17M $11.00M $4.84M $13.14M $10.01M $7.89M $5.35M
Selling, General & Admin -- -- -- -- -- $6.64M $15.33M $22.03M $20.50M $19.07M
Total Operating Expenses $27.56M $24.68M $26.96M $21.24M $13.32M $15.40M $35.18M $37.19M $31.46M $27.12M
Operating Income -$27.56M -$24.68M -$26.96M -$21.24M -$13.32M -$14.90M -$33.95M -$35.18M -$28.61M -$33.21M
EBITDA -$27.13M -$24.28M -$26.61M -$20.86M -$12.98M -$14.73M -$33.56M -$34.74M -$28.15M -$32.78M
Interest Income -- -- -- $475K $550K $16K $362K $86K $93K $31K
Income Before Tax -$26.61M -$23.49M -- -- -- -- -- -- -- --
Income Tax Expense -- $2.0K -- -- -- -- $0 $0 -- --
Net Income -$26.61M -$23.49M -$25.65M -$13.89M -$12.77M -$14.88M -$33.59M -$35.09M -$28.52M -$33.18M
Basic EPS -$0.43 -$0.43 -$0.50 -- -$0.27 -$0.72 -$2.28 -$0.53 -$0.07 -$0.10
Diluted EPS -$0.43 -$0.43 -$0.50 -- -$0.27 -$0.72 -$2.28 -$0.53 -$0.07 -$0.10
Basic Shares Outstanding 62.4M 55.0M 50.9K -- 32.8M 20.6M 14.7M 66.4M 433.2M 316.4M
Diluted Shares Outstanding 62.4M 55.0M 50.9K -- 32.8M 20.6M 14.7M 66.4M 433.2M 316.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- -- $0 $0 --
Research & Development $5.02M $4.46M $4.39M $4.63M $4.52M $4.76M $4.22M $4.30M
Total Operating Expenses $7.53M $6.87M $6.82M $6.81M $6.72M $7.46M $6.56M $6.46M
Operating Income -$7.53M -$6.87M -$6.82M -$6.81M -$6.72M -$7.46M -$6.56M -$6.46M
EBITDA -$7.40M -$6.75M -$6.69M -$6.70M -$6.62M -$7.36M -$6.46M -$6.37M
Net Income -$7.25M -$6.37M -$6.78M -$6.63M -$6.53M -$7.14M -$6.30M -$6.05M
Basic EPS -$0.08 -$0.07 -$0.08 -- -$0.11 -$0.12 -$0.11 --
Diluted EPS -$0.08 -$0.07 -$0.08 -- -$0.11 -$0.12 -$0.11 --
Basic Shares Outstanding 90.1M 87.1M 81.3M -- 59.7M 59.2M 59.2M --
Diluted Shares Outstanding 90.1M 87.1M 81.3M -- 59.7M 59.2M 59.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $16.23M $18.35M $20.65M $45.08M $2.18M $2.08M $11.33M $4.47M $7.84M $10.88M
Cash & Short-Term Investments $16.23M $18.35M $20.65M $45.08M $2.18M $2.08M $11.33M $4.47M $7.84M $10.88M
Accounts Receivable, Net -- -- -- -- -- -- $455K $504K $1.83M $274K
Inventory -- -- -- -- -- -- $1.03M $3.25M $2.70M $3.42M
Total Current Assets $17.90M $20.44M $23.06M $47.53M $2.47M $4.27M $13.11M $9.62M $13.16M $15.28M
Property, Plant & Equipment, Net $2.88M $1.69M $1.73M $1.18M $1.17M $174K $1.12M $1.02M $1.30M $1.49M
Other Non-Current Assets $1.34M $1.34M $1.34M $1.37M -- -- -- -- -- --
Total Non-Current Assets $21.50M $21.12M $22.73M $3.60M $2.98M $191K $3.49M $1.06M $1.33M $1.53M
Total Assets $39.39M $41.56M $45.80M $51.13M $5.45M $4.46M $16.60M $10.68M $14.50M $16.81M
Accounts Payable $1.03M $817K $542K $1.18M $281K $486K $1.09M $1.30M $752K $1.16M
Short-Term Debt -- -- -- -- -- $2.20M -- -- -- --
Deferred Revenue (Current) -- -- -- -- $335K $335K $335K $167K $48K $85K
Total Current Liabilities $6.60M $5.99M $5.72M $6.82M $2.09M $5.13M $6.96M $7.60M $6.62M $5.66M
Total Non-Current Liabilities $17.06M $17.96M $19.31M $0 $902K $0 $2.37M $0 $0 $0
Total Liabilities $23.66M $23.95M $25.04M $6.82M $2.99M $5.13M $9.32M $7.60M $6.62M $5.66M
Total Debt (incl. Leases) $18.86M $19.31M $20.70M $955K $1.81M $2.20M $2.60M -- -- --
Common Stock $8.0K $6.0K $5.0K $5.0K $54.65M $270.1M $264.0M $229.0M $202.2M $186.8M
Retained Earnings -$148.5M -$121.9M -$98.44M -$72.79M -$58.90M -$319.7M -$304.8M -$269.5M -$234.4M -$205.9M
Accumulated Other Comp. Income $30K $48K $140K $35K -$379K -$448K -$562K -$575K -$572K -$608K
Total Stockholders' Equity $15.73M $17.61M $20.76M $44.31M $2.46M $1.95M $7.28M $3.08M $7.88M $11.15M
Total Equity $15.73M $17.61M $20.76M $44.31M $2.46M $1.95M $7.28M $3.08M $7.88M $11.15M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $14.59M $19.89M $19.75M $16.23M $2.63M $6.79M $13.01M $18.35M
Cash & Short-Term Investments $14.59M $19.89M $19.75M $16.23M $2.63M $6.79M $13.01M $18.35M
Accounts Receivable, Net -- -- $12K -- -- -- -- --
Total Current Assets $15.83M $21.64M $21.55M $17.90M $4.17M $8.71M $14.85M $20.44M
Property, Plant & Equipment, Net $2.76M $2.85M $2.75M $2.88M $2.73M $1.58M $1.61M $1.69M
Other Non-Current Assets $892K $892K $1.34M $1.34M $1.34M $1.34M $1.34M $1.34M
Total Non-Current Assets $19.48M $20.00M $20.80M $21.50M $20.87M $20.19M $20.60M $21.12M
Total Assets $35.31M $41.64M $42.35M $39.39M $25.05M $28.91M $35.45M $41.56M
Accounts Payable $1.21M $1.20M $1.47M $1.03M $1.43M $1.76M $1.00M $817K
Total Current Liabilities $6.58M $6.66M $6.78M $6.60M $6.83M $6.72M $6.20M $5.99M
Total Non-Current Liabilities $15.51M $16.01M $16.49M $17.06M $16.91M $17.28M $17.63M $17.96M
Total Liabilities $22.09M $22.67M $23.27M $23.66M $23.74M $24.00M $23.83M $23.95M
Total Debt (incl. Leases) $17.41M $17.86M $18.27M $18.86M $18.29M $18.62M $18.94M $19.31M
Common Stock $9.0K $9.0K $8.0K $8.0K $6.0K $6.0K $6.0K $6.0K
Retained Earnings -$168.9M -$161.7M -$155.3M -$148.5M -$141.9M -$135.4M -$128.2M -$121.9M
Accumulated Other Comp. Income $32K $32K $32K $30K $141K $81K $42K $48K
Total Stockholders' Equity $13.22M $18.97M $19.09M $15.73M $1.31M $4.91M $11.62M $17.61M
Total Equity $13.22M $18.97M $19.09M $15.73M $1.31M $4.91M $11.62M $17.61M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$26.61M -$23.49M -$25.65M -$13.89M -$12.77M -$14.88M -$33.59M -$35.09M -$28.52M -$33.18M
Depreciation & Amortization $424K $400K $357K $381K $345K $164K $397K $435K $457K $432K
Stock-Based Compensation $1.48M $1.61M $1.86M $1.30M $1.67M $421K $2.92M $3.59M $3.78M $3.37M
Change in Receivables -- -- -- -- -- $461K $48K $1.22M -$1.41M $955K
Change in Inventory -- -- -- -- -- $529K -$347K -$1.18M $3.87M $10K
Change in Payables -$222K $248K -$602K -$1.94M $13K -$1.05M -$213K $554K -$419K $446K
Operating Cash Flow -$24.32M -$20.79M -$23.70M -$18.79M -$10.95M -$16.82M -$27.63M -$29.81M -$23.95M -$25.07M
Capital Expenditure -$1.17M -$556K -$887K -$338K -$572K -$330K -$493K -$163K -$265K -$490K
Free Cash Flow -$25.49M -$21.34M -$24.59M -$19.12M -$11.52M -$17.15M -$28.12M -$29.97M -$24.21M -$25.56M
Investing Cash Flow -$1.17M -$556K -$887K -$338K -$572K $68K -$493K -$163K -$265K -$490K
Common Stock Issued -- -- -- -- -- -- -- $25.94M $20.77M $19.48M
Financing Cash Flow $23.27M $19.05M $133K $63.39M $11.62M $8.60M $34.99M $26.60M $21.17M $20.45M
Net Change in Cash -$2.12M -$2.30M -$24.45M $44.26M $97K -$8.15M $6.86M -$3.37M -$3.04M -$5.08M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.25M -$6.37M -$6.78M -$6.63M -$6.53M -$7.14M -$6.30M -$6.05M
Depreciation & Amortization $129K $128K $130K $115K $105K $102K $102K $89K
Stock-Based Compensation $378K $313K $312K $467K $276K $391K $350K $402K
Change in Payables -$27K -$397K $433K -$396K -$759K $758K $175K -$26K
Operating Cash Flow -$6.39M -$6.04M -$6.20M -$6.72M -$6.35M -$6.09M -$5.16M -$5.81M
Capital Expenditure $0 -$99K -$3.0K -$274K -$823K -$71K -$5.0K -$296K
Free Cash Flow -$6.39M -$6.13M -$6.20M -$6.99M -$7.17M -$6.16M -$5.17M -$6.11M
Investing Cash Flow $0 -$99K -$3.0K -$274K -$823K -$71K -$5.0K -$296K
Financing Cash Flow $1.09M $5.83M $9.71M $20.59M $2.95M -$95K -$170K $4.83M
Net Change in Cash -$5.30M -$301K $3.52M $13.60M -$4.17M -$6.21M -$5.34M -$1.29M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- 36.3% 29.1% 35.7% -152.3%
Operating Margin -- -- -- -- -- -- -1004.9% -509.9% -359.2% -830.2%
Net Profit Margin -- -- -- -- -- -- -994.1% -508.6% -358.1% -829.5%
Return on Equity (ROE) -169.2% -133.4% -123.6% -31.3% -518.2% -763.1% -461.7% -1137.9% -361.8% -297.6%
Return on Assets (ROA) -67.5% -56.5% -56.0% -27.2% -234.2% -333.6% -202.4% -328.5% -196.7% -197.4%
Current Ratio 2.71x 3.41x 4.03x 6.97x 1.18x 0.83x 1.88x 1.27x 1.99x 2.70x
Quick Ratio 2.46x 3.07x 3.61x 6.61x 1.04x 0.41x 1.74x 0.84x 1.58x 2.10x
Debt to Equity 1.20x 1.10x 1.00x 0.02x 0.74x 1.13x 0.36x -- -- --
Revenue Growth (YoY) -- -- -- -- -- -- -51.0% -13.4% +99.1% -55.1%
Gross Profit Growth (YoY) -- -- -- -- -74.0% -59.3% -38.9% -29.5% -- -266.6%
5Y Revenue / Share Growth -- -100.0% -- -- -- -- -98.6% -98.8% -- --
10Y Revenue / Share Growth -100.0% -100.0% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -204.5% -138.7% -141.9% -169.2% -1988.2% -520.1% -204.3% -133.4%
Return on Assets (ROA) -76.6% -63.2% -64.0% -67.5% -103.9% -88.3% -67.0% -56.5%
Current Ratio 2.40x 3.25x 3.18x 2.71x 0.61x 1.30x 2.40x 3.41x
Quick Ratio 2.22x 2.99x 2.92x 2.46x 0.38x 1.01x 2.10x 3.07x
Debt to Equity 1.32x 0.94x 0.96x 1.20x 13.98x 3.79x 1.63x 1.10x
Source: SEC EDGAR CompanyFacts (CIK 0001266806) · from December 31, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:49 UTC · Open in terminal